Pierre Fenaux

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

British journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiliang Hei, Shujun Yang, Guifang Ouyang, Jolimar Hanna, Michel Lepoivre, Tony Huynh, Lorea Aguinaga, Bruno Cassinat, Nabih Maslah, Mickaël Bourge, Marie-Pierre Golinelli-Cohen, Olivier Guittet, Cindy Vallières, Laurence Vernis, Pierre Fenaux, Meng-Er Huang
Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C. British journal of haematology (2024)
Lionel Ades, Nicolas Duployez, Agnes Guerci-Bresler, Kamel Laribi, Pierre Peterlin, Norbert Vey, Sylvain Thepot, Stefan Wickenhauser, Hacene Zerazhi, Aspassia Stamatoullas, Eric Wattel, Christian Recher, Andrea Toma, Sophie Dimicoli-Salazar, Thorsten Braun, Odile Beyne-Rauzy, Jean-Pierre Marolleau, Stéphane Cheze, Sophie Park, Thomas Cluzeau, Stanislas Nimubona, Dominique Bordessoule, Riad Benramdane, Bruno Quesnel, Shanti Amé, Stéphane de Botton, Fathia Chermat, Claude Preudhomme, Sylvie Chevret, Pierre Fenaux
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations. British journal of haematology 198 (3) (2022)
Krzysztof Mądry, Karol Lis, Pierre Fenaux, David Bowen, Argiris Symeonidis, Moshe Mittelman, Reinhard Stauder, Jaroslav Čermák, Guillermo Sanz, Eva Hellström-Lindberg, Saskia M C Langemeijer, Luca Malcovati, Ulrich Germing, Mette Skov Holm, Agnes Guerci-Bresler, Dominic Culligan, Laurence Sanhes, Ioannis Kotsianidis, Corine van Marrewijk, Simon Crouch, Theo de Witte, Alexandra G Smith, null null
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry. British journal of haematology (2022)
Norman Salomao, Nabih Maslah, Anouk Giulianelli, Louis Drevon, Lorea Aguinaga, Xiaolian Gu, Bruno Cassinat, Stephane Giraudier, Pierre Fenaux, Robin Fahraeus
Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia. British journal of haematology (2022)
Vincent Marmouset, Justine Decroocq, Sylvain Garciaz, Gabriel Etienne, Amine Belhabri, Sarah Bertoli, Lauris Gastaud, Célestine Simand, Sylvain P Chantepie, Madalina Uzunov, Alexis Genthon, Celine Berthon, Edmond Chiche, Pierre-Yves Dumas, Jacques Vargaftig, Géraldine Salmeron, Emilie Lemasle, Emmanuelle Tavernier, Jérémy Delage, Marion Loirat, Nadine Morineau, Félix Blanc-Durand, Patricia Pautier, Véronique Vergé, Nathalie Auger, Myrtille Thomas, Laetitia Stefani, Marion Lepelley, Thomas Boyer, Sylvain Thépot, Marie-Pierre Gourin, Pascal Bourquard, Matthieu Duchmann, Pierre-Marie Morice, Mauricette Michallet, Lionel Ades, Pierre Fenaux, Christian Recher, Hervé Dombret, Arnaud Pagès, Christophe Marzac, Alexandra Leary, Jean-Baptiste Micol, null null
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Thibault Comont, Mathieu Meunier, Amina Cherait, Clemence Santana, Thomas Cluzeau, Bohrane Slama, Kamel Laribi, Jean-Thomas Giraud, Sophie Dimicoli, Ana Berceanu, Lenaïg Le Clech, Pascale Cony-Makhoul, Berangere Gruson, Jose Torregrosa, Laurence Sanhes, Vincent Jachiet, Marie-Agnes Azerad, Ahmad Al Jijakli, Emmanuel Gyan, Clement Gaudin, Jonathan Broner, Claire Guerveno, Thierry Guillaume, Pr Lionel Ades, Odile Beyne-Rauzy, Pierre Fenaux, null null
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life study. British journal of haematology 194 (2) (2021)
Nabih Maslah, Yantcha Diawara, Marie Sebert, Stephane Giraudier, Pierre Fenaux, Bruno Cassinat
In vitro assessment of the sensitivity to APR-246 + azacitidine combination predicts response to this combination in myelodysplastic/acute myeloid leukaemia patients. British journal of haematology 194 (4) (2021)
Thibault Comont, Mael Heiblig, Etienne Rivière, Louis Terriou, Julien Rossignol, Didier Bouscary, Virginie Rieu, Guillaume Le Guenno, Alexis Mathian, Achille Aouba, Julien Vinit, Jeremie Dion, Olivier Kosmider, Benjamin Terrier, Sophie Georgin-Lavialle, Pierre Fenaux, Arsène Mekinian, null null
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry. British journal of haematology (2021)
Pierre Peterlin, Thomas Cluzeau, Maxime Jullien, Anne-Marie Ngo Nloga, Anne Calleja, Eurydice Angeli, Patrice Chevallier, Thierry Guillaume, Alice Garnier, Amandine Le Bourgeois, Steven Le Gouill, Pierre Fenaux, Lionel Adès, Cécile Bally
Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients. British journal of haematology 190 (3) (2020)
Ursula Rochau, Igor Stojkov, Annette Conrads-Frank, Helena H Borba, Karin A Koinig, Marjan Arvandi, Corine van Marrewijk, Hege Garelius, Ulrich Germing, Argiris Symeonidis, Guillermo F Sanz, Pierre Fenaux, Theo de Witte, Fabio Efficace, Uwe Siebert, Reinhard Stauder
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group. British journal of haematology 191 (3) (2020)
Vera Adema, Laura Palomo, Andrea Toma, Olivier Kosmider, Francisco Fuster-Tormo, Rocío Benito, Rocío Salgado, Esperanza Such, María José Larrayoz, Blanca Xicoy Cirici, Jesus Maria Hernandez-Sanchez, Paolo Maietta, Alexander Neef, Michaela Fontenay, Mariam Ibañez, Maria Diez Campelo, Sara Alvarez, Jaroslaw P Maciejewski, Pierre Fenaux, Francesc Sole
Distinct mutational pattern of myelodysplastic syndromes with and without 5q- treated with lenalidomide. British journal of haematology 189 (4) (2020)
Pierre Fenaux, Uwe Platzbecker, Lionel Ades
How we manage adults with myelodysplastic syndrome. British journal of haematology 189 (6) (2019)
Louis Drevon, Alice Marceau, Odile Maarek, Wendy Cuccuini, Emmanuelle Clappier, Virginie Eclache, Thomas Cluzeau, Valentine Richez, Inès Berkaoui, Sophie Dimicoli-Salazar, Audrey Bidet, Jean-Philippe Vial, Sophie Park, Christina Vieira Dos Santos, Eléonore Kaphan, Céline Berthon, Aspasia Stamatoullas, François Delhommeau, Nassera Abermil, Thorsten Braun, Rosa Sapena, Daniel Lusina, Aline Renneville, Lionel Adès, Sophie Raynaud, Pierre Fenaux
Myelodysplastic syndrome (MDS) with isolated trisomy 8: a type of MDS frequently associated with myeloproliferative features? A report by the Groupe Francophone des Myélodysplasies. British journal of haematology 182 (6) (2018)
Sophie Park, Peter Greenberg, Aylin Yucel, Caroline Farmer, Frank O'Neill, Cisio De Oliveira Brandao, Pierre Fenaux
Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review. British journal of haematology 184 (2) (2018)
Maria Diez Campelo, Jose I Lorenzo, Raphael Itzykson, Silvia M Rojas, Céline Berthon, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, Joan Bargay, Sophie Park, María-Teresa Cedena, Dominique Bordessoule, Juan A Muñoz, Emmanuel Gyan, Esperanza Such, Sorin Visanica, Félix López-Cadenas, Stéphane de Botton, Jesús M Hernández-Rivas, Shanti Ame, Aspasia Stamatoullas, Jacques Delaunay, Celia Salanoubat, Françoise Isnard, Romain Guieze, Joan Pérez Guallar, Llorenc Badiella, Guillermo Sanz, Consuelo Cañizo, Pierre Fenaux
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries. British journal of haematology 181 (3) (2018)
Tianjiao Wang, Meagan A Jacoby, Eric J Duncavage, Christopher A Miller, Sharon Heath, Ramy Rahme, Pierre Fenaux, Lionel Ades, Aline Renneville, Bruno Cassinat, Akihiro Takeshita, Norio Asou, Yasushi Miyazaki, Hitoshi Kiyoi, Farhad Ravandi, Peter Westervelt, Lukas D Wartman, John S S Welch
Exome analysis of treatment-related AML after APL suggests secondary evolution. British journal of haematology 185 (5) (2018)
Pierre Fenaux, Petra Muus, Hagop Kantarjian, Roger M Lyons, Richard A Larson, Mikkael A Sekeres, Pamela S Becker, Amelia Orejudos, Janet Franklin
Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy. British journal of haematology 178 (6) (2017)

Pierre Fenaux.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pierre Fenaux